BioMerieux Will Use Proteome Sciences Biomarkers to Develop Stroke Dx | GenomeWeb

NEW YORK, May 23 (GenomeWeb News) - Proteome Sciences today said it has penned a license agreement with bioMerieux to use its biomarkers in blood to detect, diagnose, and monitor stroke. 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.